Clinical Trial Update: A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen. [Phase 3]

View source ↗

Summary

Phase 3 follow-up trial in differentiated thyroid cancer patients who previously participated in a study comparing standard thyroid remnant destruction versus T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Cancer

Drugs mentioned

• Thyrogen (thyrotropin alfa)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Differentiated Thyroid Cancer | Phase 3 | Status: COMPLETED